tregalizumab

Ligand id: 9864

Name: tregalizumab

No information available.
Summary of Clinical Use
Phase 2 clinical trial (NCT01999192) in patients with active RA and an inadequate response to methotrexate, was terminated early as the therapy failed to show clinical efficacy above methotrexate control [3].